On January 15, 2016, the Board of Achaogen, Inc. appointed Dr. Michael Fischbach, Ph.D., to the Nominating and Corporate Governance Committee of the Board.
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
- USD | -.--% |
|
-.--% | +278.79% |
2020 | Cipla USA Inc. cancelled the acquisition of worldwide right to C-Scape of Achaogen, Inc. (OTCPK:AKAO.Q). | CI |
2020 | Achaogen, Inc. Went Out of Business | CI |
- Stock Market
- Equities
- AKAOQ Stock
- News Achaogen
- Achaogen, Inc. Appoints Dr. Michael Fischbach to the Nominating and Corporate Governance Committee of the Board